CoChat

Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease

Open access
Cortez‐Pinto, Helena, Liberal, Rodrigo, Lopes, Susana, Machado, Mariana V., Carvalho, Joana, Dias, Teresa, Santos, Arsénio, Agostinho, Cláudia, Figueiredo, Pedro, Loureiro, Rafaela, Martins, Alexandra, Alexandrino, Gonçalo, Cotrim, Isabel, Leal, Carina, Presa, José, Mesquita, Mónica, Nunes, Joana, Gouveia, Catarina, Vale, Ana Horta e, Alves, Ana Luísa, Coelho, Mariana, Maia, Luís, Pedroto, Isabel, Banhudo, António, Pinto, João Sebastião, Gomes, Marta Vargas, Oliveira, Joana, Andreozzi, Valeska, Calinas, Filipe, on behalf of Liver.pt · 2021 · United European Gastroenterology Journal
Cited by 53

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background: The current standard of treatment in primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), although a considerable proportion of patients show incomplete response resulting in disease progression. Objective: This study aimed to assess the prevalence of incomplete response to UDCA and determine associated patients' characteristics. Methods: Patients with PBC as main diagnosis were included from a national multicentric patient registry—Liver.pt. Main endpoints included incomplete response to UDCA treatment according to Barcelona, Paris I and Paris II criteria, Globe and UK PBC scores and the association between baseline characteristics and incomplete response according to Paris II criteria. Results: A total of 434 PBC patients were identified, with a mean age of 55 years and 89.2% females. Nearly half of patients were asymptomatic at diagnosis and 93.2% had positive anti‐mitochondrial antibodies. Almost all patients (95.6%) had been prescribed at least one drug for PBC treatment. At the last follow‐up visit, 93.3% were under treatment of which 99.8% received UDCA. Incomplete response to UDCA was observed in 30.7%, 35.3%, 53.7% and 36.4% of patients according to Barcelona, Paris I, Paris II criteria and Globe score, respectively. After adjusting for age and sex, and accordingly to Paris II criteria, the risk for incomplete biochemical response was 25% higher for patients with cirrhosis at diagnosis (odds ratio [OR] = 1.25; 95% confidence interval [95%CI]: 1.02–1.54; p = 0.033) and 35% (95%CI:1.06–1.72; p = 0.016) and 5% (OR = 1.05; 95%CI:1.01–1.10; p = 0.013) for those with elevated gamma‐glutamyl transferase (GGT) and alkaline phosphatase (ALP). Conclusion: A considerable proportion of patients showed incomplete biochemical response to UDCA treatment according to Paris II criteria. Cirrhosis, elevated GGT and ALP at diagnosis were identified as associated risk factors for incomplete response. Early identification of patients at risk of incomplete response could improve treatment care and guide clinical decision to a more careful patient monitorization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ueg2.12095

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 53

Metadata

Authors
Cortez‐Pinto, H., Liberal, R., Lopes, S., Machado, M. V., Carvalho, J., Dias, T., Santos, A., Agostinho, C., Figueiredo, P., Loureiro, R., Martins, A., Alexandrino, G., Cotrim, I., Leal, C., Presa, J., Mesquita, M., Nunes, J., Gouveia, C., Vale, A. H. E., Alves, A. L., Coelho, M., Maia, L., Pedroto, I., Banhudo, A., Pinto, J. S., Gomes, M. V., Oliveira, J., Andreozzi, V., Calinas, F., & Liver.pt, O. B. O.
Venue
United European Gastroenterology Journal
Publisher
Wiley
Published
2021-06-08
Volume
9
Issue
6
Pages
699-706
ISSN
  • 2050-6406 (ISSN-L)
  • 2050-6414
OpenAlex
W3171257323
Cited by
53
References
11
FWCI
2.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease. https://app.cochat.ai/papers/10.1002/ueg2.12095
The paper
Cortez‐Pinto, H., Liberal, R., Lopes, S., Machado, M. V., Carvalho, J., Dias, T., Santos, A., Agostinho, C., Figueiredo, P., Loureiro, R., Martins, A., Alexandrino, G., Cotrim, I., Leal, C., Presa, J., Mesquita, M., Nunes, J., Gouveia, C., Vale, A. H. E., . . . Liver.pt, O. B. O. (2021). Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.